Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

A critical role for the inflammatory response in a mouse model of preneoplastic progression.

Schwertfeger KL, Xian W, Kaplan AM, Burnett SH, Cohen DA, Rosen JM.

Cancer Res. 2006 Jun 1;66(11):5676-85.

2.
3.

Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis.

Reed JR, Leon RP, Hall MK, Schwertfeger KL.

Breast Cancer Res. 2009;11(2):R21. doi: 10.1186/bcr2246. Epub 2009 Apr 24.

4.

Fibroblast growth factor receptor 1 activation in mammary tumor cells promotes macrophage recruitment in a CX3CL1-dependent manner.

Reed JR, Stone MD, Beadnell TC, Ryu Y, Griffin TJ, Schwertfeger KL.

PLoS One. 2012;7(9):e45877. doi: 10.1371/journal.pone.0045877. Epub 2012 Sep 24.

5.
7.

Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.

Medina D, Kittrell FS, Oborn CJ, Schwartz M.

Cancer Res. 1993 Feb 1;53(3):668-74.

9.

Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland.

Welm BE, Freeman KW, Chen M, Contreras A, Spencer DM, Rosen JM.

J Cell Biol. 2002 May 13;157(4):703-14. Epub 2002 May 13.

10.

Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.

Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA.

Nat Cell Biol. 2007 May;9(5):493-505. Epub 2007 Apr 22.

PMID:
17450133
11.

Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.

Bierie B, Stover DG, Abel TW, Chytil A, Gorska AE, Aakre M, Forrester E, Yang L, Wagner KU, Moses HL.

Cancer Res. 2008 Mar 15;68(6):1809-19. doi: 10.1158/0008-5472.CAN-07-5597.

12.

Macrophages promote fibroblast growth factor receptor-driven tumor cell migration and invasion in a CXCR2-dependent manner.

Bohrer LR, Schwertfeger KL.

Mol Cancer Res. 2012 Oct;10(10):1294-305. doi: 10.1158/1541-7786.MCR-12-0275. Epub 2012 Aug 14.

13.

Polyclonal development of mouse mammary preneoplastic nodules.

Kisseberth WC, Sandgren EP.

Cancer Res. 2004 Feb 1;64(3):857-63.

16.

Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.

Gallahan D, Jhappan C, Robinson G, Hennighausen L, Sharp R, Kordon E, Callahan R, Merlino G, Smith GH.

Cancer Res. 1996 Apr 15;56(8):1775-85.

17.

Transgenic Polyoma middle-T mice model premalignant mammary disease.

Maglione JE, Moghanaki D, Young LJ, Manner CK, Ellies LG, Joseph SO, Nicholson B, Cardiff RD, MacLeod CL.

Cancer Res. 2001 Nov 15;61(22):8298-305.

19.
20.

The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.

Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, Visvader JE.

Cancer Res. 2008 Oct 1;68(19):7711-7. doi: 10.1158/0008-5472.CAN-08-1949.

Supplemental Content

Support Center